Author: admin

Composite AI Market New Trends, Size, Top Key Players, Industry Analysis, Advance Technology, Future Development & Forecast – 2028

“IBM (US), SAS Institute (US), Microsoft (US), Google (US), AWS (US), Salesforce (US), BlackSwan Technologies (Israel), Oracle (US), OpenText (Canada), SAP (Germany), HPE (US), Pega (US), NVIDIA (US), Intel (US), UiPath (US), Zest AI (US), Dynamic Yield(US), DataRobot(US), H2O.ai(US), Squirro(Switzerland), CognitiveScale(US), SparkCognition (US).”
Composite AI Market by Offering (Software, Hardware, Services), Technique (Data Processing, Pattern Recognition), Application (Product Design & Development, Customer Service), Vertical and Region – Global Forecast to 2028.

The composite AI market is projected to expand from USD 0.9 billion in 2023 to USD 4.4 billion by 2028, registering a compound annual growth rate (CAGR) of 36.5% during the forecast period. Advances in deep learning and natural language processing within AI technology have streamlined the process of designing and integrating multiple AI models into composite AI systems.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158760226  

Software to hold the largest market share during the forecast period

Composite AI software typically provides a platform or framework enabling seamless integration and orchestration of different AI models or algorithms. It allows users to leverage the diverse capabilities of these AI components to solve multifaceted challenges and make more informed decisions. With composite AI software, organizations can build sophisticated AI applications that can process and analyze diverse data types, understand complex patterns, generate insights, make predictions, and perform tasks that require a combination of AI techniques. The software enables the development of intelligent systems that can handle real-world complexities and deliver robust and reliable results.

Data mining & machine learning to grow at the highest CAGR during the forecast period

Data mining and machine learning techniques are crucial in implementing Composite AI solutions in the market. Combining data mining and machine learning techniques within composite AI solutions enables the system to analyze vast amounts of data, discover patterns, make predictions, and optimize decision-making. These techniques form the foundation for developing and deploying AI models and algorithms that power composite AI systems. They enable composite AI solutions to harness the power of data and deliver intelligent, adaptive, and context-aware capabilities across various domains and applications.

Product design & development to hold the largest market share during the forecast period

Product design and development applications play a vital role in composite AI solutions by facilitating the creation, iteration, and improvement of AI-powered products and services. Product design and development applications enable the creation of prototypes and simulations of AI-powered systems. Product design and development applications emphasize user-centric design principles, ensuring that the composite AI solution is intuitive, usable, and meets the needs of the end users. Hence, product design and development applications are crucial in shaping the user experience, integrating AI components, facilitating iterative development, ensuring scalability, monitoring performance, and addressing compliance and ethics considerations within composite AI solutions.

Asia Pacific to hold the highest CAGR during the forecast period

The Asia Pacific segment is anticipated to grow at the highest CAGR during the forecast period, driven by advancements in AI technologies, increasing data availability, and the growing digital transformation initiatives in various industries.  As AI technologies continue to advance and organizations embrace digital transformation, the adoption of Composite AI solutions is expected to grow further in the region.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=158760226  

Unique Features in the Composite AI Market

Composite AI combines various AI techniques, such as machine learning, deep learning, and natural language processing (NLP), to create robust and flexible systems. This integration allows businesses to address complex challenges that cannot be solved by a single AI model, enabling more comprehensive solutions.

The ability to merge diverse AI approaches improves decision-making by leveraging multiple perspectives and methodologies. Composite AI systems analyze data from various angles, delivering more accurate and actionable insights for strategic and operational decisions.

Composite AI offers high flexibility, allowing organizations to tailor AI systems to specific needs. By combining different models and technologies, businesses can create solutions that align with their unique processes and objectives, ensuring better outcomes.

The incorporation of sophisticated NLP capabilities enables composite AI systems to understand and process human language more effectively. This feature is particularly valuable in applications like chatbots, virtual assistants, and sentiment analysis, enhancing human-machine interaction.

By using a combination of AI models, composite AI systems achieve higher accuracy and performance. This multi-model approach reduces biases and limitations inherent in individual models, resulting in more reliable predictions and analyses.

Major Highlights of the Composite AI Market

Composite AI stands out for its ability to integrate multiple AI technologies, such as deep learning, machine learning, and natural language processing (NLP). This capability enables the creation of versatile systems that address complex, multi-dimensional challenges.

Businesses are increasingly seeking AI solutions tailored to their unique needs. Composite AI allows organizations to customize systems by combining models and algorithms, ensuring higher relevance and efficiency in addressing industry-specific problems.

By leveraging a combination of AI models, composite AI delivers improved accuracy and performance. This multi-model approach reduces biases and compensates for the limitations of individual techniques, resulting in more robust and reliable outcomes.

Composite AI is driving innovation by broadening the scope of AI applications. It enables the development of hybrid solutions that solve problems across domains, fostering creativity and advancing the overall AI landscape.

Composite AI is gaining traction across industries such as healthcare, finance, retail, and manufacturing. Use cases include predictive maintenance, fraud detection, supply chain optimization, and personalized customer experiences, showcasing its versatility and impact.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=158760226  

Top Companies in the Composite AI Market

Key players operating in the composite AI market include IBM (US), SAS Institute (US), Microsoft (US), Google (US), AWS (US), Salesforce (US), BlackSwan Technologies (Israel), Oracle (US), OpenText (Canada), SAP (Germany), HPE (US), Pega (US), NVIDIA (US), Intel(US), UiPath(US), Zest AI(US), Dynamic Yield(US), DataRobot(US), H2O.ai (US), Squirro(Switzerland), CognitiveScale(US), SparkCognition(US), Diwo (US), ACTICO(Germany), Kyndi(US), Nauto(US), Netra(US), and Exponential AI (US).

These composite AI vendors have adopted various organic and inorganic strategies to sustain their positions and increase their global market shares.

IBM

IBM is a multinational technology and consulting corporation that offers infrastructure, hosting, and consulting services. The company operates through five major business segments: software, consulting, infrastructure, and financing. IBM caters to various industries: aerospace & defense, education, healthcare, oil & gas, automotive, electronics, insurance, retail & consumer products, banking & finance, energy & utilities, life sciences, telecommunications, media & entertainment, chemicals, government, manufacturing, travel & transportation, construction, and metals & mining. The company offers the IBM Watson Assistant in the composite AI market. It maintains strong partner relationships with leading IT providers, like AWS, Adobe, Cisco, KPMG, Kyndryl, Microsoft, Oracle, Salesforce, Samsung, SAP, ServiceNow, and Workday. The company is active in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.

SAS Institute

SAS Institute is an American multinational analytics software developer, which creates and sells a suite of analytics software that facilitates access to, management of, analysis of, and reporting on data to support decision-making. The corporation is the world’s largest privately held software company; most Fortune 500 companies utilize it. Its analytics platform enables enterprises to connect data and gain actionable business insights. Apart from IoT data management solutions and services, the company offers streaming analytics solutions for fraud and security intelligence, cloud analytics, data and decision management, and business intelligence. The company offers a robust, scalable, and open edge-to-enterprise analytics platform, which bridges the gap between IT and operational environments. It incorporates visualization, statistical modeling, and predictive and prescriptive analytics to deliver expertise in IoT analytics and AI, ML, and deep learning, to reduce risks and extract business value. It applies advanced analytics and AI to IoT to reduce downtime. SAS Institute caters to many industries, including banking, capital markets, communications, education, government, healthcare, insurance, life sciences, manufacturing, and retail. The company has a geographic presence in the Americas, Europe, the Middle East, Africa, and Asia Pacific. SAS Visual Text Analytics is an open platform NLP solution in the AI market provided by SAS Institute that aids in data preparation and visualization, parsing, trend analysis, information extraction, hybrid modeling approaches, sentiment analysis, and flexible deployment with native support for 33 languages.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/composite-ai-market-158760226.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Composite AI Market New Trends, Size, Top Key Players, Industry Analysis, Advance Technology, Future Development & Forecast – 2028

Unconventional Journal: An Unanticipated Life by S. Thrall – A Poetic Journey Towards Healing and Self-Discovery

USA – Unconventional Journal: An Unanticipated Life, the latest work by acclaimed poet S. Thrall, offers readers a powerful exploration of resilience, trauma, and personal growth. Comprising a collection of short yet impactful poems, this book has already been a guiding light for individuals confronting life’s challenges, providing comfort, reflection, and a deeper connection to self.

A Safe Space for Healing and Reflection

This unique collection, available now on Amazon, creates a space for readers to examine their inner worlds. Through each carefully crafted verse, S. Thrall invites readers to reflect on their personal experiences, embrace their emotions, and foster healing. Through her powerful words, readers have been able to confront their feelings and experiences in a meaningful way. This book has become an essential tool for those seeking solace and understanding amid their struggles.

Empowering Readers to Face Trauma and Foster Resilience

The poems within Unconventional Journal: An Unanticipated Life are designed to resonate with those experiencing trials and tribulations, encouraging them to explore their inner landscapes. S. Thrall’s words provide both a mirror and a guide, helping readers uncover new perspectives on their journeys. “By engaging with the themes in her poetry, my clients have discovered insights into their paths, fostering healing and personal growth.”

A Testament to the Power of Words

S.Thrall’s work stands as a testament to the power of poetry in personal development. The themes of resilience, spiritual connection, and self-empowerment woven throughout Unconventional Journal: An Unanticipated Life make it more than just a book; it’s a lifeline for those navigating complex emotions. Readers across the globe are finding peace, strength, and clarity within its pages, transforming the way they approach life’s challenges.

Where to Find Unconventional Journal: An Unanticipated Life

Unconventional Journal: An Unanticipated Life is available for purchase on Amazon. For more information or to explore the profound impact of S. Thrall’s poetry, reach out to the author directly.

Contact:

S. Thrall

Email: unconventionalpoems@gmail.com

Website: Amazon Link

Media Contact
Company Name: S. Thrall
Contact Person: S. Thrall
Email: Send Email
Country: United States
Website: https://www.amazon.com/Unconventional-Journal-Unanticipated-Life-S-ebook/dp/B0DL65LZ3Y/ref=sr_1_1?dib=eyJ2IjoiMSJ9.cZlYcSbymHEyKQXHxQb07G_sehy2JdI7-C_8Ho2IRUsidYIkSJJOnFiYnGtmfn0D9VZ5zZMmYVpdDn0n6QnYZ8HqXaIyyiG6hvxUsSI5ok9j6BQbkQ554hgtWfmz-2Qh5KpopRQz5A0ovmkx206fzPVPCOVIlHk4YYcU29Hay79lnPQmp3JvyWLh05wcrk9Mh40JredQpgEkWYGgB5Pip5QJ5PBTnUW-jeq3K6f3ey0.ubT2clyzIQJrBvHP79PHCu2SIhpMbSrpls9xSbbnTFw&dib_tag=se&keywords=unconventional+journal&qid=1731295758&s=books&sr=1-1

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Unconventional Journal: An Unanticipated Life by S. Thrall – A Poetic Journey Towards Healing and Self-Discovery

Experience Hassle-Free Bali Adventures with Hey Bali’s Airport Transfer and Free Portable Wi-Fi

Bali, Indonesia – November 18, 2024 – Hey Bali is excited to introduce an unbeatable offer for travelers visiting Bali: a seamless airport transfer service combined with free portable Wi-Fi rental for up to 30 days. With this exclusive deal, visitors can kickstart their Bali journey stress-free while staying effortlessly connected.

As one of the top travel service providers in Bali, Hey Bali understands the importance of convenience, comfort, and connectivity. This service ensures that from the moment tourists arrive at Bali Ngurah Rai International Airport, they are treated to a private, comfortable ride to their destination. Plus, the complimentary portable Wi-Fi allows travelers to stay online for navigation, communication, or sharing their Bali adventures with loved ones.

Bali Airport Transfers Tailored for You

Whether heading to popular spots like Ubud, Kuta, or Nusa Dua, or exploring lesser-known gems like Amed, Tulamben, and Flores, Hey Bali offers airport transfers that suit every traveler’s needs. The vehicles are private, ensuring a personalized experience for up to four passengers, with professional drivers who know the ins and outs of Bali’s roads.

Discover more about this offer here:

Free Wi-Fi for Up to 30 Days

One of the highlights of Hey Bali’s airport transfer service is the inclusion of free portable Wi-Fi rental for up to 30 days. Whether you’re navigating the streets of Bali, sharing picturesque views on social media, or staying connected for work, this feature is designed to make your trip smoother and more enjoyable.

Making Travel Meaningful with Hey Bali

Hey Bali’s mission is to make travel meaningful, not only for tourists but also for the local communities. The company prioritizes sustainable tourism by supporting small businesses, respecting cultural heritage, and giving back to underprivileged children in Bali, Lombok, and Flores.

Through this initiative, Hey Bali ensures that travel becomes a force for positive change. Guests are invited to embrace purposeful travel by leaving a positive impact on the places they visit. By choosing Hey Bali, travelers not only enjoy premium services but also contribute to a better future for local communities.

Why Choose Hey Bali?

  • Hassle-free booking and reliable service.

  • Affordable pricing with added perks like portable Wi-Fi.

  • Dedication to creating meaningful travel experiences.

Whether you’re a first-time visitor or a Bali regular, Hey Bali’s airport transfer with free Wi-Fi rental is the perfect way to begin your adventure.

For more information and to book your transfer, visit Hey Bali Airport Transfer.

Contact Information:

Hey Bali

Kubu Anyar Street No 88x, Kuta – Badung – Bali – Indonesia – 80361

ask@heybali.info

+62853 3805 5757

Start your Bali adventure with ease and purpose. Let Hey Bali redefine your travel experience today!

Media Contact
Company Name: Hey Timur Indonesia Ltd
Contact Person: Daisy Silvia
Email: Send Email
Country: Indonesia
Website: https://heybali.info/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Experience Hassle-Free Bali Adventures with Hey Bali’s Airport Transfer and Free Portable Wi-Fi

Peripheral Neuropathic Pain Market Size in the 7MM was ~USD 12,000 Million, which is expected to increase by 2034

The Peripheral Neuropathic Pain Market is poised for significant growth due to the increasing awareness of the condition, advancements in therapeutic interventions, and the rising global burden of peripheral neuropathies.

 

DelveInsight’s “Peripheral Neuropathic Pain Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Peripheral Neuropathic Pain, historical and forecasted epidemiology as well as the Peripheral Neuropathic Pain market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

 

Discover Key Insights into the Peripheral Neuropathic Pain Market with DelveInsight’s In-Depth Report @ Peripheral Neuropathic Pain Market Size

 

Key Takeaways from the Peripheral Neuropathic Pain Market Report

  • In November 2024:- Vertex Pharmaceuticals-A Phase 3, Randomized, Double-blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy. The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN).
  • In November 2024:- Afasci Inc.- This is a randomized, double-blind, placebo-controlled, multicenter Phase II study of the efficacy, safety, tolerability, and PK of oral AFA-281 in 300 patients with painful lumbosacral radiculopathy (PLSR). Patients will be randomized in to the placebo group or doses of AFA-281, titrated over 2 weeks to reach planned daily doses for Weeks 3 and 4. Trials will be conducted simultaneously at 3 sites to meet enrollment targets. The primary efficacy endpoint is 24-hour average pain score based on the 0-10-point Numeric Pain Rating Scale (NPRS) and key secondary endpoint is Oswestry Disability Index (ODI), rates of adverse events, and PK, among others.
  • In 2023, the United States recorded the highest incidence of PNP among the 7MM, with ~35,200,000 reported cases.
  • The 7MM saw the highest number of severe cases in post-operative and post-traumatic PNP, while moderate cases predominated in PHN in terms of severity.
  • Estimates indicate that in 2023, the EU4 and the UK collectively reported approximately 19.3 million cases, with Germany representing the largest share at around 35% of the total cases.
  • In 2023, diabetic peripheral neuropathy (DPN) accounted for the highest number of cases in the US, comprising approximately 50% of the total cases.
  • The leading Peripheral Neuropathic Pain Companies such as Helixmith, WEX Pharmaceuticals Inc., Lexicon Pharmaceuticals Inc., Bayer, AlzeCure Pharma, Grünenthal, Mallinckrodt Pharmaceuticals., Pfizer, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., and others
  • Promising Peripheral Neuropathic Pain Therapies such as ENGENSIS/VM202 (donaperminogene seltoplasmid), Halneuron, LX9211, BAY2395840, ACD440 gel, and others

 

Stay ahead in the Peripheral Neuropathic Pain Therapeutics Market with DelveInsight’s Strategic Report @ Peripheral Neuropathic Pain Market Outlook

 

Peripheral Neuropathic Pain Epidemiology Segmentation in the 7MM

  • Total Cases of Peripheral Neuropathic Pain
  • Type-specific Cases of Peripheral Neuropathic Pain
  • Treated Cases of Peripheral Neuropathic Pain

 

Download the report to understand which factors are driving Peripheral Neuropathic Pain Epidemiology trends @ Peripheral Neuropathic Pain Prevalence

 

Marketed Peripheral Neuropathic Pain Drugs

  • QUTENZA (capsaicin): Grünenthal and Averitas Pharma

QUTENZA (capsaicin) 8% topical system, a non-systemic, non-opioid pain relief delivered in the form of a patch, indicated for treating neuropathic pain associated with postherpetic neuralgia or associated with diabetic peripheral neuropathy (DPN) of the feet in adults. Capsaicin is an agonist for the transient receptor potential vanilloid 1 receptor (TRPV1), an ion channel-receptor complex expressed on nociceptive nerve fibers in the skin. QUTENZA is marketed and distributed by Averitas. Currently, it is being evaluated under a Phase III trial in post-surgical neuropathic pain. The trial is expected to be completed by October 2024, with an estimated enrollment of 408 participants.

  • ZTLIDO (lidocaine): Scilex Pharmaceuticals

ZTLIDO is a topical lidocaine system (1.8%) approved for relieving pain associated with postherpetic neuralgia. ZTLIDO is designed as a lighter, thinner product with improved adhesion relative to LIDODERM (lidocaine patch 5%) while providing a bioequivalent delivery of lidocaine in an efficient drug delivery system. Lidocaine is a local amide anesthetic; it blocks sodium ion channels required for initiating and conducting neuronal impulses.

 

Emerging Peripheral neuropathic pain Drugs

  • SEMDEXA (SP-102): Scilex Holding Company

SP-102 is a preservative-free, surfactant-free, and particulate-free, novel epidural steroid injection (ESI) formulation of 10 mg dexamethasone sodium phosphate in a viscous gel solution for subacute lumbosacral radicular pain (Sciatica). Its extended local effect provides durable pain relief and significant improvement in functioning from a single injection with rapid onset.

  • Adezunap (AP707): Apurano Pharmaceuticals

Apurano Pharmaceuticals’ investigational drug AP707, featuring the THC-focused active ingredient adezunap, has received EMA approval for DISCOVER approval studies. Utilizing the patented PuranoTec manufacturing process, cannabis flower undergoes processing to create an aqueous nanodispersion of cannabinoids, primarily ?-9-THC. Administered as a sublingual mouth spray, this dispersion allows for rapid and efficient absorption through the oral mucosa, facilitated by a water-soluble shell termed the smart coating. These SmartLipids, encapsulating lipophilic cannabinoids, remain stable in aqueous environments and can directly enter the bloodstream due to their small particle size (

 

Get In-Depth Knowledge on Peripheral Neuropathic Pain Market Trends and Forecasts with DelveInsight @ Peripheral Neuropathic Pain Treatment Market

 

Peripheral Neuropathic Pain Market Outlook

Peripheral Neuropathic Pain Companies, such as Scilex Holding Company, Grünenthal and Averitas Pharma, Eli Lilly and Company, Mitsubishi Tanabe Pharma Corporation, AstraZeneca, Asahi Kasei Pharma, Veloxis Pharmaceuticals, and others, are evaluating their lead candidates in different stages of clinical development, respectively. They aim to investigate their products for the treatment of Peripheral Neuropathic Pain.

 

Scope of the Peripheral Neuropathic Pain Market Report

  • Study Period: 2020–2034
  • Coverage: 7MM
  • Peripheral Neuropathic Pain Companies: Helixmith, WEX Pharmaceuticals Inc., Lexicon Pharmaceuticals Inc., Bayer, AlzeCure Pharma, Grünenthal, Mallinckrodt Pharmaceuticals., Pfizer, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., and others
  • Peripheral Neuropathic Pain Therapies: ENGENSIS/VM202 (donaperminogene seltoplasmid), Halneuron, LX9211, BAY2395840, ACD440 gel, and others
  • Peripheral Neuropathic Pain Therapeutic Assessment: Peripheral Neuropathic Pain current marketed and Peripheral Neuropathic Pain emerging therapies

 

Unlock Strategic Insights with DelveInsight’s Comprehensive Peripheral Neuropathic Pain Market Report @ Peripheral Neuropathic Pain Market Drivers and Barriers

 

Table of Content

1. Peripheral Neuropathic Pain Market Report Introduction

2. Executive Summary for Peripheral Neuropathic Pain

3. SWOT analysis of Peripheral Neuropathic Pain

4. Peripheral Neuropathic Pain Patient Share (%) Overview at a Glance

5. Peripheral Neuropathic Pain Market Overview at a Glance

6. Peripheral Neuropathic Pain Disease Background and Overview

7. Peripheral Neuropathic Pain Epidemiology and Patient Population

8. Country-Specific Patient Population of Peripheral Neuropathic Pain

9. Peripheral Neuropathic Pain Current Treatment and Medical Practices

10. Peripheral Neuropathic Pain Unmet Needs

11. Peripheral Neuropathic Pain Emerging Therapies

12. Peripheral Neuropathic Pain Market Outlook

13. Country-Wise Peripheral Neuropathic Pain Market Analysis (2020–2034)

14. Peripheral Neuropathic Pain Market Access and Reimbursement of Therapies

15. Peripheral Neuropathic Pain Market Drivers

16. Peripheral Neuropathic Pain Market Barriers

17. Peripheral Neuropathic Pain Appendix

18. Peripheral Neuropathic Pain Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: yash bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Peripheral Neuropathic Pain Market Size in the 7MM was ~USD 12,000 Million, which is expected to increase by 2034

Don’t Fear The OpEx: AI and The Age of Productivity

“Amicus AI Chart of Labor Productivity Post Generative AI”
Amicus AI Advisors reports a shift in U.S. labor productivity driven by generative AI, signaling potential wage growth amid inflation concerns. Fed Chair Powell noted this could boost wages, with a 2.3% rise in Q2 2024. Generative AI bridges productivity gaps, empowering non-technical workers. CIO Dr. Leonidas Tam expects balanced AI investments to mirror the stable wage growth of the 1950s-60s, paving the way for a new era of shared prosperity and realigning capital-labor dynamics.

San Francisco, CA – November 18, 2024 – New analysis from Amicus AI Advisors, LLC highlights a significant shift in U.S. labor productivity, driven by the rapid adoption of generative AI technologies. As inflation concerns persist, this trend suggests the potential for sustained wage growth, signaling a promising development for the economy.

At last Thursday’s rate cut press conference, Federal Reserve Chair Jerome Powell noted, “If we see productivity more sustainable at these high levels, then that would sustain higher wage gain.” This follows a notable 2.3% surge in U.S. labor productivity in Q2 2024, which surpassed expectations.

Amicus AI Advisors draws historical context from Nobel Prize-winning economists Daron Acemoglu and Simon Johnson: “US median real wages (hourly compensation) grew at above 2.5 percent per year between 1949 and 1973. Then from 1980 onward, median wages all but stopped growing.”

Economist Robert Solow famously summarized this paradox: “The computer age was everywhere except for the productivity statistics.”

Their analysis shows a turning point. For decades, computers struggled with many routine intellectual tasks, limiting their impact on overall productivity. However, generative AI is now bridging this gap, democratizing access to advanced problem-solving across a wide range of industries. This transformation enables even non-technical workers to complete complex tasks, significantly boosting productivity.

“With higher productivity, we can expect wages to rise,” says Dr. Leonidas Tam, Chief Investment Officer at Amicus AI Advisors. “Much like the 1950s and 1960s, when balanced investments in automation maintained a stable labor share of income, generative AI is poised to foster a new era of balanced growth.”

Acemoglu and Johnson reinforce this point: “As a result of the broadly balanced investments in automation and new tasks in the 1950s and 1960s… labor share of income in manufacturing remained broadly constant, hovering close to 80 percent between 1950 and the early 1980s.”

Amicus AI Advisors determines that companies leading with AI, integrating new tasks and capabilities, are well-positioned to replicate this balanced growth, ushering in a modern era of shared prosperity. By strategically deploying generative AI, businesses can boost productivity while ensuring equitable wage increases, realigning the relationship between capital and labor.

About Amicus AI Advisors, LLC

Amicus AI Advisors, LLC is a premier research firm specializing in AI-driven economic analysis and strategic advisory services. Leveraging cutting-edge AI technologies, the firm delivers actionable insights, helping clients navigate complex market dynamics and capitalize on emerging trends.

Media Contact
Company Name: Amicus AI Advisors, LLC
Contact Person: Wayne Tam
Email: Send Email
Country: United States
Website: https://amicus.ai/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Don’t Fear The OpEx: AI and The Age of Productivity

Crowds Gather for The Christmas Chain Premieres in Hollywood

November 18, 2024 – Beverly Hills, CA – The holiday spirit was in full swing as The Christmas Chain, a heartwarming new film, made its grand debut at the Fine Arts Theater in Beverly Hills and the Gary Marshall Theater in Burbank. The premiere, hosted by the Mendez National Institute of Transplantation Foundation (MNITF) and Suzanne DeLaurentiis Productions, drew an enthusiastic crowd of attendees, including fans, supporters, and Hollywood insiders.

Celebrity cast members Eric Roberts and Michael Paré lit up the red carpet alongside key stars Stephen Green, Carissa Murray, and Tyler Andrews. Producers Nicole Mendez and Suzanne DeLaurentiis delighted guests with a festive reception complete with special holiday-themed gifts.

Set against the backdrop of Christmas, The Christmas Chain tells the story of twin brothers Dez and Jerome as they embark on a life-changing journey home for the holidays. When Jerome suffers a life-threatening kidney injury, the brothers cross paths with Sabrina, a compassionate musician whose extraordinary act of generosity transforms their lives. The film celebrates the power of giving and the profound ripple effects of one person’s kindness.

The event was made possible by the generous support of sponsors, including Pink’s Hot Dogs, Tona, Booze and Brews, Maralyn & Justin Dooley, Total Financial Wealth Management, TFS Financial Insurance Services, and Parking Company of America.

Now available for streaming on Tubi, Apple TV, Vudu, Google Play, and iTunes, The Christmas Chain is poised to become a holiday favorite, inspiring audiences with its message of hope and the spirit of giving.

For more information, please contact Suzanne DeLaurentiis Productions LLC at delaurentiisllc@gmail.com. To learn more about kidney health and transplantation, visit MNITF.org

About MNITF

The Mendez National Institute of Transplantation Foundation (MNITF) is a non-profit organization committed to advancing transplantation science and providing essential healthcare education about kidney disease and transplantation to at-risk communities.

Media Contact
Company Name: Suzanne DeLaurentiis PR
Contact Person: Suzanne DeLaurentiis
Email: Send Email
Phone: (310) 801-3675
Country: United States
Website: http://suzannedelaurentiisproduction.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Crowds Gather for The Christmas Chain Premieres in Hollywood

Data Center Construction Market to Register Considerable Growth with a Remarkable 7.5% CAGR through 2031, Growing Demand for Data Storage to Propel Market

“Skyquest Technology”
Data Center Construction Market Size, Share, Growth Analysis, By Type(Tier I, Tier II, Tier III, Tier IV), By Application(Electrical Infrastructure and Mechanical Infrastructure), By Region – Industry Forecast 2024-2031

Data Center Construction Market size was valued at USD 213.55 billion in 2022 and is poised to grow from USD 229.57 billion in 2023 to USD 409.43 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The data center construction market is witnessing speedy growth impacted by the rising demand for data processing and storage due to the growth of digital transformation, IoT, and cloud computing. The key driving factors comprise the emergence of 5G technology, regulatory compliance, focus on sustainability and energy efficiency, and geographic expansion. Furthermore, the market is propelled by innovations in construction technologies and techniques, thus creating a dynamic landscape for novel data center projects. Also, investments from tech giants and rising need for disaster recovery solutions is impacting the market growth.

Download a detailed overview:

https://www.skyquestt.com/sample-request/data-center-construction-market

There is an increased emphasis towards the development of environmentally friendly data centers that use renewable energy sources like wind and solar power. Several companies are actively adopting energy-efficient designs and cooling techniques to reduce their carbon footprint. The emphasis on sustainability is not only impacted by regulatory needs, but also by the growing CSR (corporate social responsibility) objectives. Moreover, since latency becomes vital for use cases like real-time data processing and IoT, there is a rising trend witnessed towards establishing data centers (edge). These small facilities are situated near users to streamline speedy data processing and data access. This trend is fueling investments in distributed infrastructure to aid local processing requirements.

Heavy Adoption of Advanced Cooling Solutions and Integration of Automation and AI Are Key Market Developments

Recent developments in cooling systems like immersion cooling and liquid cooling are gaining popularity in data center construction. These techniques offer more efficiency than conventional air cooling and aid in managing heat generation from the growingly dense configurations of the server. For instance, liquid cooling may considerably lessen energy consumption and is gaining prominence as data centers are actively scaling up their operations. The incorporation of automation and artificial intelligence in data center construction is notably changing operations. AI-based technologies are increasingly used for enhancing security protocols, enhancing energy usage, and predictive maintenance. Automation in construction procedures may enhance accuracy, simplify workflows, and minimize labor costs, thus increasing efficiency of construction processes.

  • In August 2024, Hitachi, Ltd. and Singtel sighed a MoU to join hands on the GPU cloud and next-generation data centers in Japan and wider region of Asia under the brand name Singtel Digital InfraCo segment. This strategic alliance will combine expertise of both the companies, allowing end-to-end integration of data center, comprising green power solutions, storage unit, and cooling systems, and data management.
  • In June 2024, Hewlett Packard Enterprise and Danfoss announced their alliance to offer HPE IT Sustainability Services – Data Center Heat Recovery. It is a heat recovery module (off-shelf) that assists businesses to handle and value excess heat as they move towards eco-friendlier IT facilities.
  • In June 2024, Cisco launched an inclusive data center solution in partnership with NVIDIA that offers the storage, server, AI software, and networking equipment to the enterprises to deploy several applications and generative AI on-premises.

 

Request Free Customization of this report:

https://www.skyquestt.com/speak-with-analyst/data-center-construction-market

 

This report covers the following segments:  

  1. A.    Type
  2. Tier I
  3. Tier II
  4. Tier III
  5. Tier IV

 

  1. B.     Application
  2. Electrical Infrastructure
  3. Mechanical Infrastructure

 

The report covers the following players:  

  1. Turner Construction Company (US)
  2. DPR Construction (US)
  3. AECOM (US)
  4. Skanska AB (Sweden)
  5. Jacobs Engineering Group Inc. (US)
  6. Clark Construction Group, LLC (US)
  7. Hensel Phelps Construction Co. (US)
  8. Structure Tone (US)
  9. Fluor Corporation (US)
  10. Mortenson (US)

 

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/data-center-construction-market

 

Ongoing Transformations to Evolve Landscape of Data Center Construction in Future

Leading developments like implementation of improved technologies, emphasis on hybrid infrastructure, integration of automation and AI, and improved regulatory compliance are transforming the facility operation and design. Simultaneously, trends like modular construction, increased security measures, edge computing, and sustainability denote dedication towards resilience and efficacy. As businesses are adopting digital landscape, data center construction is projected for continuous innovations and growth.

Related Report:

Print On Demand Market

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/data-center-construction-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Data Center Construction Market to Register Considerable Growth with a Remarkable 7.5% CAGR through 2031, Growing Demand for Data Storage to Propel Market

Unmanned Systems Market worth $43.54 Billion by 2030, at a CAGR of 8.2%

“Unmanned Systems Market”
The global Unmanned Systems Market in terms of revenue was estimated to be worth $27.13 billion in 2024 and is poised to reach $43.54 billion by 2030, growing at a CAGR of 8.2% during the forecast period.

According to a research report “Unmanned Systems Market by Type (Unmanned Aerial Vehicle, Unmanned Marine Vehicle, Unmanned Ground Vehicle), Application (Defense, Government & Law Enforcement, Commercial, Consumer, Other), Mode of Operation and Region – Global Forecast to 2030″ published by MarketsandMarkets, the unmanned systems market is projected to reach USD 43.54 billion by 2030, from USD 27.13 billion in 2024, at a CAGR of 8.2%.

The growth of the unmanned systems market is driven by several factors, including the rising demand for Autonomous Systems. In the defense industry, autonomous technologies provide enhanced operational capabilities with reduced risk to human lives. Militaries are increasingly relying on unmanned aerial vehicles (UAVs), unmanned ground vehicles (UGVs), and maritime drones for surveillance, reconnaissance, and combat missions. These systems offer advantages such as extended endurance, faster decision-making, and the ability to operate in dangerous environments without direct human intervention. The need for more efficient, flexible, and resilient systems to address complex, modern-day threats is pushing governments to heavily invest in these technologies.

Download PDF Brochure @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=18210274

Browse 379 market data Tables and 107 Figures spread through 370 Pages and in-depth TOC on “Unmanned Systems Market by Type (Unmanned Aerial Vehicle, Unmanned Marine Vehicle, Unmanned Ground Vehicle), Application (Defense, Government & Law Enforcement, Commercial, Consumer, Other), Mode of Operation and Region – Global Forecast to 2030”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/unmanned-systems-market-18210274.html

Based on Unmanned Aerial Vehicle types, the Strategic UAV segment is estimated to capture largest share of the market during the forecast period

Strategic Unmanned Aerial Vehicles (UAVs) are expected to dominate the UAV  by type market during the forecast period due to their critical role in long-range, high-altitude missions, primarily for defense and military applications. These UAVs, designed for intelligence, surveillance, and reconnaissance (ISR) missions, provide real-time data over extended distances and for longer durations, making them invaluable for military operations. Countries are increasingly investing in strategic UAVs to enhance their defense capabilities, especially with rising geopolitical tensions and the need for constant monitoring of borders and high-threat zones. Additionally, their ability to carry advanced payloads such as sensors, communication relays, and precision-guided munitions makes them multifunctional tools in combat and reconnaissance missions. MQ-9 Reaper, which is widely used for counterterrorism and intelligence gathering. The growing focus on autonomous warfare, cost-effective operations compared to manned aircraft, and the need for air superiority in complex conflict environments further reinforce the dominance of strategic UAVs. As militaries globally emphasize modernizing their defense infrastructure, strategic UAVs are set to be a driver of this growth.

Based on Unmanned Ground Vehicles type, the Wheeled UGVs segment is forecasted to grow at highest CAGR during forecast period

Wheeled Unmanned Ground Vehicles (UGVs) are projected to have the highest CAGR during the forecast period due to their mobility, and cost-effectiveness across various industries. Wheeled UGVs are more efficient on smoother terrains, such as urban environments and industrial settings, where they can quickly cover large areas with minimal energy consumption compared to tracked or legged UGVs. Their simpler mechanical design allows for easier maintenance and lower operational costs, making them attractive for commercial sectors like agriculture, logistics, and security. In military and defense, wheeled UGVs are increasingly used for perimeter surveillance, explosive ordinance disposal (EOD), and reconnaissance missions due to their speed and ease of maneuverability. for example iRobot PackBot highlight their role in bomb disposal and hazardous material handling in urban warfare. As industries push for operational efficiency and automation, wheeled UGVs are positioned to dominate the market.

North America is expected to capture the largest share during the forecast period in 2024.

The unmanned systems market in North America is expected to lead in 2024. The region, led by the US, is a global leader in technological innovation, particularly in the defense and aerospace sectors, where unmanned systems such as drones, unmanned ground vehicles (UGVs), and unmanned marine vehicles (UMVs) are extensively used. Government support through significant investments in research and development, as well as favorable policies for the integration of autonomous systems into both military and commercial applications, further fuels growth.

The major players include Northrop Grumman (US), Lockheed Martin Corporation (US), Teledyne Technologies Inc. (US), BAE Systems (UK), DJI (China), Thales (France), Israel Aerospace Industries (Israel), Boeing (US), General Dynamics Corporation (US), Textron Inc. (US), L3harris Technologies Inc. (US), Elbit Systems Ltd. (Israel), Leonardo S.p.A (Italy), Edge PJSC Group (UAE), and ST Engineering (Singapore).

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Delray Beach
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/unmanned-systems-market-18210274.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Unmanned Systems Market worth $43.54 Billion by 2030, at a CAGR of 8.2%

Leading Real Estate Agent in Oakland, CA, Advocates Seasonal Buying Strategies for Optimal Deals

Oakland, CA – Erin Chan-Adams, a premier real estate agent in Oakland, CA, is guiding clients through the complexities of the housing market with innovative seasonal buying strategies. Her insight into the cyclical nature of real estate offers buyers a strategic advantage, particularly during the less competitive summer and winter months.

Erin emphasizes the importance of timing in real estate investments. “The seasonal ebb and flow in Oakland can significantly affect both inventory levels and pricing,” explains Erin. Her expertise allows clients to capitalize on these fluctuations, providing them with opportunities to purchase at optimal times. As a respected Realtor agent in Oakland, CA, Erin’s advice is invaluable to those looking to make a savvy investment.

The strategy involves detailed market analysis and planning to ensure that buyers are ready to act when the time is right. Erin’s role as a Realtor in Oakland, CA includes educating clients on the benefits of purchasing during off-peak seasons, when competition is lower and better deals are often available. This approach not only aids in finding the best properties but also in negotiating more favorable terms.

Moreover, Erin’s understanding of the market extends beyond just buying. As a seasoned real estate selling agent in Oakland, CA, she advises sellers on the best times to list their properties to maximize exposure and profit. Her dual expertise in buying and selling ensures that all her clients receive comprehensive and strategic real estate advice tailored to their specific needs.

For those considering entering the Oakland real estate market, Erin Chan-Adams offers a wealth of knowledge and a strategic approach to buying and selling homes. “Visit https://chanadamsrealty.com/ to learn more about how strategic timing can benefit your real estate decisions,” Erin invites potential clients. Whether you’re looking to buy low or sell high, Erin’s seasonal strategies provide a unique advantage in the competitive Oakland market.

Media Contact
Company Name: Erin Chan-Adams | Real Estate Agent in Oakland CA
Contact Person: Erin Chan-Adams
Email: Send Email
Phone: 1 415-370-7228
Address:6450 Moraga Ave
City: Oakland
State: California 94611
Country: United States
Website: https://chanadamsrealty.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Leading Real Estate Agent in Oakland, CA, Advocates Seasonal Buying Strategies for Optimal Deals

Polycythemia Vera Market Size in the 7MM is ~USD 1,800 million in 2023, estimated DelveInsight

Polycythemia Vera Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition.

 

DelveInsight’s “Polycythemia Vera Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

 

Discover Key Insights into the Polycythemia Vera Market with DelveInsight’s In-Depth Report @ Polycythemia Vera Market Size

 

Key Takeaways from the Polycythemia Vera Market Report

  • In November 2024:- PharmaEssentia Japan K.K.- The study is to evaluate the long-term safety and efficacy of P1101 in PV or ET patients who participated in Study A19-201 or Study P1101 ET. The subjects who have completed the 52-week P1101 treatment duration in Study A19-201 will start treatment with P1101 at the dose at Week 50. The subjects who have completed the follow-up/end-of-study visit in Study P1101 ET will start treatment with P1101 at the dose at Week 50. The subjects who were treated with anagrelide will start treatment with P1101 at a dose of 250 μg. The dose of P1101 during this study may be increased or decreased up to 500 μg depending on the condition.
  • In November 2024:- Ionis Pharmaceuticals Inc.- The main purpose of this study is to evaluate the efficacy of sapablursen in reducing the frequency of phlebotomy and in improving quality of life assessments in participants with polycythemia vera. This is a Phase 2a, multi-center, randomized, open-label study of sapablursen in up to 40 participants with PD-PV. The study consists of 4 periods: 1) Screening Period: up to 7 weeks; 2) Treatment Period: 37 weeks 3) Treatment Extension Period: 36 weeks; 4) Post-treatment Period: 13 weeks.
  • In November 2024:- This is a randomized, open-label, multicenter, two-arm study to assess the efficacy and safety of ropeginterferon alfa-2b for patients with PV. The entire study period is 60 weeks, including a main treatment phase (32 weeks), an extension treatment phase (24 weeks), and a safety follow-up phase (four weeks). However, the study may be extended for additional period of treatment after Week 60 pending the primary endpoint analysis at Week 32. Approximately 70 patients with PV will be enrolled.
  • In November 2024:- Novartis Pharmaceuticals- This is a long term safety study for patients that have been treated with either ruxolitinib or a combination of ruxolitinib with panobinostat, on a Novartis or Incyte sponsored study, who have been judged by the study Investigator to benefit from ongoing treatment.
  • The United States contributed to the largest prevalent population of Polycythemia Vera, acquiring ~58% of the 7MM in 2023. Whereas EU4 and the UK, and Japan accounted for around 32% and 10% of the total population share, respectively, in 2023.
  • The total number of prevalent cases of Polycythemia Vera in the United States was around 182,000 cases in 2023.
  • Among the EU4 countries, Germany accounted for the largest number of Polycythemia Vera cases, followed by France, whereas Spain accounted for the lowest number of cases in 2023.
  • According to DelveInsight estimates, there were around 72,000 cases of asymptomatic and 107,000 cases of symptomatic Polycythemia Vera in the United States in 2023. The prevalence is projected to increase during the forecasted period.
  • Among the age-specific data, 55–64 years of age group was found to be most prevalent in Polycythemia Vera, accounting for nearly 32% of the total cases.
  • In 7MM, approximately 70% of the patient share is attributed to males, whereas only 30% of females suffer from Polycythemia Vera.
  • The leading Polycythemia Vera Companies such as Protagonist Therapeutics, Imago BioSciences, Italfarmaco, Silence Therapeutics, Ionis Pharmaceutical, and many others.
  • Promising Polycythemia Vera therapies such as Rusfertide (PTG-300), Bomedemstat (IMG-7289), Ruxolitinib + Abemaciclib, P1101, Itacitinib, Givinostat (ITF2357), Sapablursen (IONIS-TMPRSS6-LRx), SLN124, PPMX-T003, and others.

 

Stay ahead in the Polycythemia Vera Therapeutics Market with DelveInsight’s Strategic Report @ Polycythemia Vera Market Outlook

 

Polycythemia Vera Epidemiology Insights in the 7MM

  • Total Polycythemia Vera Prevalent Cases
  • Prevalent Population of Polycythemia Vera Based On Symptoms
  • Polycythemia Vera Gender-Specific Cases
  • Prevalence of Polycythemia Vera By Gene Mutation
  • Prevalence of Polycythemia Vera Based On Risk
  • Polycythemia Vera Age-Specific Prevalence

 

Download the report to understand which factors are driving Polycythemia Vera epidemiology trends @ Polycythemia Vera Prevalence

 

Polycythemia Vera Marketed Drugs

  • JAKAFI/JAKAVI (ruxolitinib): Incyte/Novartis

JAKAFI/JAKAVI (ruxolitinib) is an oral inhibitor of the JAK 1 and JAK 2 tyrosine kinases. It is approved for treating adult patients resistant to or intolerant of hydroxyurea. Incyte’s flagship product, Jakafi, received approval as second-line therapy for Polycythemia Vera patients in December 2014 in the United States, followed by approvals in both the EU and Japan in 2015. Incyte reported that out of all the drug prescriptions, approximately 30–35% of the prescriptions were in Polycythemia Vera. This attributes to Jakafi’s well-established therapeutic efficacy and traction in patients as a second-line therapy.

  • BESREMi (ropeginterferon alfa-2b): PharmaEssentia/AOP Orphan Pharmaceuticals

PharmaEssentia’s BESREMi, a monopegylated proline interferon is a new entrant for first as well as more advanced-line Polycythemia Vera patients without symptomatic splenomegaly; it is one of the first to be approved for condition. BESREMi was approved in Q4 2021 in the US; meaningful sales began in 2022. Before the US launch, the drug was approved in the EU in 2019 and has been available in Germany, France, and the UK since 2020, whereas in April 2022, the drug was approved for reimbursement by Italy’s National Health Service (SSN).

BESREMi is a subcutaneous pen self-administered once every 2 weeks or monthly during long-term maintenance with a wholesale acquisition cost (WAC) of approximately USD 180,000 annually in the United States, whereas in certain Europe, annual pricing range from USD 60,000 to 110,000.

 

Emerging Polycythemia Vera Drugs

  • Rusfertide (PTG-300): Protagonist Therapeutics

Rusfertide (PTG-300), which is being investigated by Protagonist Therapeutics, is a novel injectable synthetic mimetic of the natural hormone hepcidin. The drug could potentially be the next first-line therapy competitor. The Phase II REVIVE Study demonstrated very promising results in both high-and low-risk patients, whereas if Phase III VERIFY study results are successful, the drug is expected to launch in late 2024 or early 2025. Given its very different mechanism of action compared to BESREMi and JAKAFI, the drug could become a viable alternative in earlier lines. Likewise, even the key opinion Leaders (KOLs) are bullish when it comes to the conventional route of administration once a week along with the safety and efficacy of this drug, which is expected to reduce the need for Phlebotomy for patients at both low and high risk, expanding the applicability of the drug. The US FDA granted Rusfertide ODD and FTD for the treatment of Polycythemia Vera.

 

Get In-Depth Knowledge on Polycythemia Vera Market Trends and Forecasts with DelveInsight @ Polycythemia Vera Treatment Market

 

Polycythemia Vera Companies

Protagonist Therapeutics, Imago BioSciences, Italfarmaco, Silence Therapeutics, Ionis Pharmaceutical, and many others.

 

Scope of the Polycythemia Vera Market Report

  • Coverage- 7MM
  • Study Period- 2020-2034
  • Polycythemia Vera Companies- Protagonist Therapeutics, Imago BioSciences, Italfarmaco, Silence Therapeutics, Ionis Pharmaceutical, and many others.
  • Polycythemia Vera Therapies- Rusfertide (PTG-300), Bomedemstat (IMG-7289), Ruxolitinib + Abemaciclib, P1101, Itacitinib, Givinostat (ITF2357), Sapablursen (IONIS-TMPRSS6-LRx), SLN124, PPMX-T003, and others.
  • Polycythemia Vera Market Dynamics: Polycythemia Vera Market Drivers and Barriers
  • Polycythemia Vera Unmet Needs, KOL’s views, Analyst’s views, Polycythemia Vera Market Access and Reimbursement

 

Unlock Strategic Insights with DelveInsight’s Comprehensive Polycythemia Vera Market Report @ Polycythemia Vera Market Drivers and Barriers

 

Table of Content

1 Key Insights

2 Report Introduction

3 Executive Summary of Polycythemia Vera (Polycythemia Vera)

4 Key Events

5 Epidemiology and Market Methodology

6 Polycythemia Vera Market Overview at a Glance

7 Disease Background and Overview

8 Epidemiology and Patient Population of Polycythemia Vera in the 7MM

9 Patient Journey

10 Key Endpoints in Polycythemia VeraClinical Trials

11 Marketed Drugs

12 Emerging Drugs

13 Polycythemia Vera (Polycythemia Vera): 7MM Analysis

14 Unmet Needs

15 SWOT Analysis

16 KOL Views

17 KOL interviews on Polycythemia Vera

18 Polycythemia Vera (Polycythemia Vera): Market Access and Reimbursement

19 Appendix

20 DelveInsight Capabilities

21 Disclaimer

22 About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: yash bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Polycythemia Vera Market Size in the 7MM is ~USD 1,800 million in 2023, estimated DelveInsight